Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
This study has been completed.
Study NCT00284089.   Last updated on November 17, 2006.
Information provided by Novartis
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Choroidal Neovascularization
Macular Degeneration
Neoplasm Metastasis
Neovascularization, Pathologic
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Neoplasms
Neoplastic Processes
Pathologic Processes
Retinal Degeneration
Retinal Diseases
Uveal Diseases
Interventions listed in this trial
Ranibizumab
Sponsors listed in this trial
Novartis


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services